HCA Healthcare (NYSE:HCA) COO Jon Foster Sells 10,000 Shares of Company Stock

Key Points

• HCA COO Jon Foster sold 10,000 shares at an average price of $514.07, totaling about $5.14 million; the transaction was disclosed in an SEC filing.
• HCA’s latest quarter beat estimates, reporting adjusted EPS of $7.22 versus $6.65 expected and revenue of $19.85 billion versus $19.33 billion expected; revenue grew 3.6% year over year.
• The company declared a quarterly dividend of $0.78 per share, equivalent to an annualized $3.12 and a 0.6% yield.

HCA Healthcare, Inc. (NYSE:HCA - Get Free Report) COO Jon Foster sold 10,000 shares of HCA Healthcare stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $514.07, for a total value of $5,140,700.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

HCA Healthcare Price Performance

Shares of HCA traded down $13.04 during midday trading on Friday, hitting $494.44. 1,462,203 shares of the company traded hands, compared to its average volume of 1,355,955. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The firm has a market cap of $103.28 billion, a P/E ratio of 16.38, a PEG ratio of 1.71 and a beta of 1.11. The stock has a 50-day moving average of $442.16 and a 200-day moving average of $445.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, beating the consensus estimate of $6.65 by $0.57. The company had revenue of $19.85 billion during the quarter, compared to analysts' expectations of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. HCA Healthcare's revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.96 earnings per share. Sell-side analysts forecast that HCA Healthcare, Inc. will post 30.15 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, December 15th. HCA Healthcare's payout ratio is 10.34%.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
• Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
• Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
• Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
• Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
• Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
• Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement

Hedge Funds Weigh In On HCA Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. Sunbelt Securities Inc. boosted its stake in HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company's stock worth $2,954,000 after buying an additional 3,945 shares in the last quarter. Sei Investments Co. raised its stake in shares of HCA Healthcare by 27.5% during the first quarter. Sei Investments Co. now owns 467,796 shares of the company's stock worth $221,380,000 after acquiring an additional 100,764 shares in the last quarter. SEB Asset Management AB bought a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $75,534,000. Darsana Capital Partners LP boosted its stake in shares of HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company's stock valued at $428,879,000 after purchasing an additional 350,000 shares in the last quarter. Finally, Fund 1 Investments LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at $975,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Morgan Stanley dropped their price objective on HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a research note on Monday, July 27th. UBS Group lowered their price target on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a report on Monday, July 27th. KeyCorp lifted their price target on HCA Healthcare from $435.00 to $490.00 and gave the company an "overweight" rating in a research report on Wednesday, October 28th. Cantor Fitzgerald restated an "overweight" rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $480.13.

About HCA Healthcare

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.

The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.

Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.